Abstract
In the absence of commercial kits for serological studies specifically for hepatitis E virus (HEV) infection of swine, the capsid protein of a swine genotype 3 HEV was expressed using a recombinant baculovirus. This antigen was used in an enzyme-linked immunosorbent assay (ELISA) for detection of anti-HEV antibodies. Estimation of sensitivity and specificity was carried out in comparison with a commercial serological assay using sera from pigs infected experimentally with HEV genotype 3, negative sera from SPF pigs and swine sera collected at slaughterhouses. Since a “gold standard” is not available, a latent-class Bayesian approach for correlated tests was used to estimate the sensitivity and specificity of both tests. External field and experimental data were used to determine the parameters of Beta prior distributions. The estimated mean sensitivity of the commercial test was 0.47 with a 95% credibility interval of 0.39–0.55, whereas the estimated mean sensitivity of the genotype 3-based assay was 0.92 [0.81–0.99]. The estimated specificities were 0.98 [0.93–0.99] and 0.98 [0.95–0.99] for the genotype 3-based test and commercial test, respectively. In conclusion, genotype 3-antigen derived from swine HEV is a better candidate for assessing hepatitis E serology in swine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
